Introduction
============

Congenital clubfoot (CCF) is a common congenital malformation that seriously endangers children\'s health ([@b1-etm-0-0-6013]). The pathogenesis of CCF is unclear. Previous findings showed that common impacts of multiple factors lead to the occurrence of CCF ([@b2-etm-0-0-6013],[@b3-etm-0-0-6013]). At present, an increasing number of studies have focused on CCF. With the development of genetics and genetic technology, it has been found that multiple genes play an important role in the occurrence and development of CCF ([@b4-etm-0-0-6013]).

Transcription factor homeobox gene (*HOX* gene) belongs to the homeobox family, which constitutes genes that specifically regulate and control biological form and structure in living organism ([@b5-etm-0-0-6013],[@b6-etm-0-0-6013]). Previous findings have shown that HOX gene mutation is closely related to the occurrence and development of CCF ([@b7-etm-0-0-6013]).

The present study explored the pathogenetic process of CCF by detecting the levels of iNOS and NO, as well as the factors associated with inflammation and apoptosis, and the expression of *HOX* gene in CCF was detected by RT-PCR and western blot analysis, in order to provide guidance for genetic diagnosis, precaution and treatment of CCF.

Patients and methods
====================

### Patient data

Patients included in the present study comprised children who were hospitalized and had undergone operations in Jiangyang Hospital between April 2009 and May 2015. All the child patients had clinical symptoms of typical CCF. If combined with other malformations the patients were excluded by examination and operational definite diagnosis. The CCF group comprised 35 cases of children with CCF (male, 18 cases; female, 17 cases), aged 0.6--9 years, with an average age of 3.4 years. Muscle specimens were from the children who had undergone CCF operations, and 100 mg lower leg gastrocnemius was collected for the study. The control group comprised 34 cases of children without congenital malformation who had trauma operations of lower legs or had taken out internal fixation after the traumas of lower legs (male, 20 cases; female, 14 cases). These childrend were aged 1.1--10 years, with an average age of 6.8 years. Approximately 100 mg lower leg gastrocnemius was collected as muscle specimens from the same location as the CCF group.

Signed informed consent forms were obtained from the children\'s family for the collection and use of the specimens. The study was approved by the Ethics Committee of the Affiliated Hospital of Southwest Medical University (Luzhou, China).

### Primary reagents

iNOS and NO detection kit (Jiancheng, Nanjing, China); bicinchoninic acid (BCA) protein assay kit (Biyuntian, Shanghai, China); TRIzol total RNA extraction kit; reverse transcription-polymerase chain reaction (RT-PCR) reverse transcription kit (both from Tiangen, Beijing, China); glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and HOX monoclonal antibodies and secondary antibodies (CST, Boston, MA, USA) were used in the study.

Experimental methods
--------------------

### Measurement of iNOS

The serum samples of the patients in the control and CCF groups were collected. The levels of iNOS and NO in the sera were measured and the results of the data were analyzed in accordance with the protocols provided by Nanjing Jiancheng Biology Co., Ltd.

### RT-PCR analysis

RT-PCR analysis was carried out using the following steps:

### a) Extraction of total RNA

The collected tissues were rapidly transferred to Eppendorf (EP) tubes that contained 1.5 ml RNAiso Plus extracting solution (the tissues needed homogenizing thoroughly). After 5 min standing, the samples were disintegrated completely and centrifuged for 5 min at 12,000 × g at 4°C. The supernatan t was carefully absorbed to be transferred to new EP tubes. Chloroform (0.2 ml) was added to the supernatant, and then mixed evenly. After 5 min standing at room temperature, the samples were centrifuged for 15 min at 12,000 × g at 4°C, the supernatant was absorbed, and then the same volume of isopropanol was added, mixed evenly, and left to stand for 10 min at room temperature. The samples were then centrifuged for 10 min at 12,000 × g at 4°C, the supernatant was discarded carefully, and the sediment was preserved. Subsequently, 1 ml 75% ethyl alcohol was added, and the samples were mixed evenly, followed by centrifugation for 5 min at 12,000 × g at 4°C. The supernatant was carefully discarded, and the process was repeated. After the RNA sediment was washed, the liquid was discarded. Finally, when the ethyl alcohol volatilized completely, the RNase-free water was added.

### b) Purity analysis and content calculation of total RNA

Total RNA solution (4 µl) was diluted with 1 ml RNase-free water, and the absorbance values were measured at wavelengths of 260, 280 and 320 nm. If optical density (OD~260~/OD~280~) was between 1.8 and 2.2, it showed that the purity of sample RNA met the requirement. RNA concentration (µg/µl) = (OD~260~-OD~320~) × dilution ratio × 0.04.

### c) Reverse transcription

After partial RNA solution was diluted with RNase-free water to get 1 µg/µl solution, reverse transcription solution was prepared in accordance with the instructions of the PrimeScript^®^ RT reagent kit with gDNA eraser kit, into which the corresponding RNA samples were added, and reverse transcription was performed to obtain cDNA. The obtained cDNA was kept at −20°C.

### d) qPCR analysis

According to the protocol of the SYBR^®^ Premix Ex Taq™ II (Tli RNaseH Plus) kit, the levels of mRNA were measured. Primer sequences of corresponding RNA are shown in [Table I](#tI-etm-0-0-6013){ref-type="table"}.

### Western blot analysis

The collected tissues of the control and CCF groups were washed respectively with ice-cold physiological saline. The protein concentrations were measured by BCA protein assay kit, and preserved for standby application after being packed separately at −80°C. The procedure was performed according to the protocol of the total protein extration kit. Immunoprecipitation (IP) lysate containing phenylmethanesulfonyl fluoride (PMSF) and protease inhibitor was added, and the tissues were placed on ice for full grinding. After tissue homogenate was centrifuged for 10 min at 4°C and 12,000 × g, the supernatant was taken; after it was centrifuged for 20 min again at 4°C and 12,000 × g, the supernatant was taken. Then, after the supernatant and protein qualification were carried out according to the protocol of the protein kit, the protein samples containing an equal quantity of total protein were loaded and placed onto sample loading wells, and electrophoresed at constant voltage of 220 V, and the electrophoresis stopped when the bromophenol blue reached the bottom of the gel. According to molecular weight of target protein, the gel was cut and placed into transfer buffer. Polyvinylidene fluoride (PVDF) membrane was cut to keep the target band only, and the PVDF membrane was soaked in methyl alcohol for 10 sec. The PVDF membrane and filter paper were placed in a transfer buffer and then a transmembrane device in the order of positive electrode, filter paper, PVDF membrane, gel, filter paper, negative electrode, and PVDF membrane was transferred for appropriate time at constant voltage of 110 V, for the protein of the gel to transfer to the PVDF membrane. The PVDF membrane to which protein was adhered was placed in 5% skim milk powder, and then agitated and sealed for 3 h at room temperature. The membrane was then placed in rabbit anti-human GAPDH monoclonal antibody (dilution, 1:1,000; cat. no. 2118) and rabbit anti-human HOX primary monoclonal antibodies (dilution, 1:1,000; cat. no. 90944) for incubation overnight at 4°C. The next day, the PVDF membrane was completely washed with Tween-20/Tris-buffered salt (TTBS) (10 min/time, 3 times), and then goat anti-rabbit secondary polyclonal antibody (dilution, 1:2,000; cat. no 7074) were added and incubated for 1 h at room temperature. After washing with TTBS (10 min/time, 3 times), enhanced chemiluminescence (ECL) color-substrate solution was added dropwise for color development photography.

### Statistical analysis

Experimental data were expressed with mean ± standard deviation, and statistical analysis for experimental results was made by Statistical Product and Service Solutions 17.0 (SPSS 17.0; Chicago, IL, USA). Mean comparison between the two groups were obtained using the Student\'s t-test. For mean comparisons among the groups one-way analysis of variance (ANOVA) was used. SNK test was used as post hoc test. Statistical significance was set at P\<0.05.

Results
=======

### Measured results of iNOS and NO

As shown in [Fig. 1](#f1-etm-0-0-6013){ref-type="fig"}, the levels of iNOS and NO between the control and CCF groups were significantly different. The levels of iNOS and NO in the CCF group were significantly higher than those in the control group, which indicated that obvious oxidative damage occurred in the CCF group.

### RT-PCR results of the factors associated with inflammation

Total RNA was extracted respectively from tissue samples of the control and CCF groups. After RT-PCR, the expression of IL-1β, IL-6 and TNF-α in CCF group was significantly higher than those in control group ([Fig. 2](#f2-etm-0-0-6013){ref-type="fig"}). It could thus be seen that excessive expression of inflammatory factors generated serious inflammatory reaction in pathogenic process of CCF.

### RT-PCR results of the factors associated with apoptosis

As shown in [Fig. 3](#f3-etm-0-0-6013){ref-type="fig"}, the expression of Fas, FasL and Bax in CCF group was significantly higher than that in the control group. Thus, the excessive expression of the factors related to apoptosis resulted in serious tissue apoptosis and damage in pathogenic process of CCF.

### RT-PCR result of HOX mRNA

The expression of HOX RNA in tissue samples of the control and CCF groups was detected, and the results are shown in [Fig. 4](#f4-etm-0-0-6013){ref-type="fig"}. As shown the expression quantity of HOX in CCF group was significantly higher than that in the control group, which indicated that the expression of HOX mRNA in CCF was very high and was associated with the development of CCF.

### Expression of HOX protein in the control and CCF groups

Results of the western blot analysis revealed the expression of HOX protein in the tissues of the control and CCF groups. As shown in [Fig. 5](#f5-etm-0-0-6013){ref-type="fig"}, HOX protein was expressed highly in the tissues of CCF group, and the expression quantity was greater than that in control group.

Discussion
==========

CCF is a common congenital malformation that threatens children\'s health and seriously impacts on foot function ([@b8-etm-0-0-6013]). At present, the pathogenesis of CCF is not very clear, there are main theories such as germplasm defect theory, developmental block theory, theories of neurogenic myogenic and angiogenic abnormality in embryonic period and theory of fiber curliness denaturation ([@b9-etm-0-0-6013]--[@b11-etm-0-0-6013]). Currently, the most respected theory is the theory of neuromuscular lesion ([@b12-etm-0-0-6013]). In recent years, with the rapid development of epidemiologic studies, we identified that genetic factors play an important role ([@b13-etm-0-0-6013]) in the pathogenesis process of CCF.

The development process of limbs is a very complex process regulated and controlled by multiple genes ([@b14-etm-0-0-6013]). The development process refers to the sequence of successive expression of multiple genes within different periods and different spaces ([@b15-etm-0-0-6013]). Transcription factor *HOX* gene is an effective gene in the development of limbs that has been extensively studied ([@b16-etm-0-0-6013]). *HOX* gene plays a very important role in many parts of the body, including nerves, muscles, bones and blood vessels. Thus, diseases on limbs can be caused once *HOX* gene has mutations or abnormal expression ([@b17-etm-0-0-6013]). The occurrence of CCF may be the abnormal expression of *HOX* gene in the development process of limbs, and then abnormal embryonic development is caused to lead to CCF ([@b18-etm-0-0-6013]). Some studies showed that *HOX* gene adjusted the factors associated with apoptosis, thus it indicates that *HOX* gene may be the important susceptibility gene of CCF ([@b19-etm-0-0-6013],[@b20-etm-0-0-6013]).

This study included 35 cases of child patients with CCF as the CCF group, and 34 cases of children with congenital malformation as the control group. iNOS and NO kits were used to measure the levels of iNOS in the sera of the control and CCF groups. IL-1β, IL-6, TNF-α, Fas, FasL, Bax and the expression of HOX mRNA in the tissues of both groups were detected by RT-PCR. The expression of HOX in the control and CCF groups was detected via western blot analysis. Experimental results showed that oxidative damage, inflammatory factors and apoptotic factors appeared in CCF group. RT-PCR and western blot analysis showed that, HOX was highly expressed in CCF group, where the expression quantity of HOX was significantly higher than that in normal tissues.

In conclusion, the present study made some progress in determining the aetiological agent of CCF and genetic expression of HOX. However, more follow-up studies should be conducted because the pathogenesis of CCF is very complex on its genetic aspects. We expect to discover other susceptibility genes, study the association between HOX and other genes, and further study on interaction mechanism among multiple genes is required. We believe that HOX is of great significance in gene therapy and HOX indicates a new direction for the diagnosis and treatment of CCF in the future based on this study.
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###### 

Primer sequences of related genes were analyzed by RT-PCR analysis.

  Gene names   Primer sequences
  ------------ ---------------------------------
  *IL-1β*      5′-3′ CTGAGCACCTTCTTTCCCTTCA
               3′-5′ TGGACCAGACATCACCAAGCT
  *IL-6*       5′-3′ TGGCTGAAAAAGATGGATGCT
               3′-5′ TCTGCACAGCTCGGCTTGT
  *TNF-α*      5′-3′ TGTAGCCCATGTTGTAGCAAACC
               3′-5′ GAGGACCTGGGAGTAGATGAGGTA
  *Fas*        5′-3′ ACATGGACAAGAACCATTATGCTGA
               3′-5′ CTGGTTTGCACTTGCACTTGGTA
  *FasL*       5′-3′ CATGCAGCAGCCCATGAATTAC
               3′-5′ CTCTAGGCCCACAAGATGGACAG
  *Bax*        5′-3′ CAGGATGCGTCCACCAAGAA
               3′-5′ CGTGTCCACGTCAGCAATCA
  *HOX*        5′-3′ GTGATCTGTAATCCCTATGAG
               3′-5′ TFGTTACCCTGCATTACGATG
  *β-actin*    5′-3′ GAGCCGGGAAATCGTGCGT
               3′-5′ GGAAGGAAGGCTGGAAGATG

PCR, polymerase chain reaction; IL-1β, interleukin-1β; TNF-α, tumor necrosis factor-α; Fas, fatty acid synthase; FasL, Fas ligand; Bax, Bcl-2-associated X; HOX, homeobox.
